Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -39.69%93.06M | 19.11%126.84M | 39.52%129.35M | -25.54%505.92M | 10.21%140.06M | 6.49%154.3M | -59.66%106.5M | -35.39%92.71M | 0.16%679.46M | -23.22%127.08M |
| Cost of revenue | -35.41%84.02M | 16.23%109.77M | 40.30%118.57M | -27.84%457.06M | 19.65%135.29M | -3.84%130.07M | -62.93%94.44M | -35.13%84.51M | 2.35%633.38M | -17.19%113.07M |
| Gross profit | -62.67%9.05M | 41.65%17.08M | 31.53%10.78M | 6.04%48.86M | -65.94%4.77M | 151.50%24.24M | 30.86%12.06M | -38.00%8.2M | -22.67%46.08M | -51.65%14.01M |
| Operating expense | -7.52%7.3M | -7.73%7.54M | 12.47%8.25M | 5.12%36.88M | -22.26%8.71M | 28.97%7.9M | -13.12%8.17M | -12.35%7.33M | 21.65%35.09M | 57.99%11.21M |
| Selling and administrative expenses | -11.93%6.96M | -12.00%7.19M | 7.46%7.88M | 5.23%35.41M | -25.80%7.24M | 28.97%7.9M | -13.12%8.17M | -12.35%7.33M | -10.31%33.65M | -38.13%9.76M |
| -Selling and marketing expense | --0 | 0.00%4.1K | --6K | -38.81%4.1K | --0 | --0 | -38.81%4.1K | --0 | -95.89%6.7K | --0 |
| -General and administrative expense | -11.93%6.96M | -12.01%7.19M | 7.38%7.87M | 5.23%35.41M | -25.80%7.24M | 28.97%7.9M | -13.10%8.17M | -12.35%7.33M | -9.92%33.65M | -38.13%9.76M |
| Other operating expenses | --348.25K | --349.48K | --367.17K | 1.66%1.47M | 1.59%1.47M | ---- | ---- | ---- | 116.75%1.45M | --1.45M |
| Total other operating income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -50.00%11K | ---- |
| Operating profit | -89.33%1.74M | 145.44%9.54M | 193.02%2.54M | 8.99%11.98M | -240.74%-3.94M | 365.18%16.34M | 2,141.25%3.89M | -82.18%865.58K | -64.25%10.99M | -87.20%2.8M |
| Net non-operating interest income (expenses) | 126.78%993.59K | 31.90%1.23M | 19.99%1.22M | -251.60%-4.2M | -68.86%1.06M | -416.07%-3.71M | -6.30%930.84K | 464.13%1.02M | -81.48%2.77M | -79.27%3.41M |
| Non-operating interest income | -17.03%2.08M | -7.03%2.39M | -8.57%2.46M | -13.54%6.65M | -29.99%2.39M | -11.84%2.51M | -10.05%2.57M | 44.94%2.69M | -60.82%7.69M | -79.12%3.41M |
| Non-operating interest expense | -82.51%1.09M | -29.12%1.16M | -25.89%1.24M | 95.46%11.24M | --1.33M | 271.95%6.22M | -12.05%1.64M | -0.09%1.68M | -1.64%5.75M | ---- |
| Total other finance cost | ---- | ---- | ---- | 53.80%-383K | ---- | ---- | ---- | ---- | 29.63%-829K | ---- |
| Net investment income | 92.34%-608.11K | -392.38%-1.22M | -83.34%188.88K | -86.39%1.55M | -40.61%2.51M | -108.86%-7.94M | -102.84%-248.57K | 299.19%1.13M | 235.09%11.38M | 1,477.36%4.22M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -14.39%2.18M | 553.85%2.55M | ||||||||
| Income from associates and other participating interests | -22.39%1.41M | -63.98%811.68K | 511.50%2.26M | 860.91%8.46M | 4,042.38%4.94M | 376.49%1.82M | 256.90%2.25M | -7,470.44%-549.77K | 270.54%880K | 51.53%-125.22K |
| Special income (charges) | -56.81%1.46M | 232.65%3.38M | ||||||||
| Less:Other special charges | ---- | ---- | ---- | 56.81%-1.46M | ---- | ---- | ---- | ---- | -232.65%-3.38M | ---- |
| Other non-operating income (expenses) | -66.89%319.88K | -47.52%275.13K | 54.15%552.94K | 57.46%929K | 38.52%541.06K | -79.96%966.26K | -36.68%524.21K | 18.56%358.71K | -93.06%590K | -94.62%390.6K |
| Income before tax | -48.34%3.86M | 44.70%10.63M | 139.32%6.76M | -31.33%22.35M | -52.27%5.11M | 22.69%7.47M | -33.22%7.35M | -40.69%2.82M | -44.37%32.55M | -77.24%10.7M |
| Income tax | -86.77%564.76K | 38.58%2.82M | -46.69%1.4M | 39.07%9.66M | -74.45%923.7K | 2,659.71%4.27M | 89.17%2.04M | 24.85%2.62M | 392.48%6.94M | 21.93%3.62M |
| Net income | 2.93%3.29M | 47.04%7.81M | 2,488.94%5.37M | -50.42%12.69M | -40.94%4.18M | -46.06%3.2M | -46.50%5.31M | -92.23%207.24K | -55.15%25.6M | -83.92%7.08M |
| Net income continuous operations | 2.93%3.29M | 47.04%7.81M | 2,488.94%5.37M | -50.42%12.69M | -40.94%4.18M | -46.06%3.2M | -46.50%5.31M | -92.23%207.24K | -55.15%25.6M | -83.92%7.08M |
| Noncontrolling interests | -79.19%31.75K | 192.95%47.83K | -46.82%31.97K | -64.18%120K | -25.91%59.04K | 185.84%152.57K | -222.37%-51.46K | -62.36%60.11K | -91.19%335K | -97.77%79.68K |
| Net income attributable to the company | 7.04%3.26M | 44.74%7.76M | 3,525.01%5.33M | -50.24%12.57M | -41.11%4.12M | -48.17%3.05M | -45.75%5.36M | -94.13%147.13K | -52.58%25.27M | -82.70%7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 7.04%3.26M | 44.74%7.76M | 3,525.01%5.33M | -50.24%12.57M | -41.11%4.12M | -48.17%3.05M | -45.75%5.36M | -94.13%147.13K | -52.58%25.27M | -82.70%7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 6.15%0.0069 | 44.74%0.0165 | 3,666.67%0.0113 | -50.19%0.0267 | -41.61%0.0087 | -48.00%0.0065 | -45.71%0.0114 | -94.34%0.0003 | -52.61%0.0536 | -82.65%0.0149 |
| Diluted earnings per share | 6.15%0.0069 | 44.74%0.0165 | 3,666.67%0.0113 | -50.19%0.0267 | -41.61%0.0087 | -48.00%0.0065 | -45.71%0.0114 | -94.34%0.0003 | -52.61%0.0536 | -82.65%0.0149 |
| Dividend per share | 0 | -41.67%0.007 | 0 | 0.00%0.012 | 0 | 0 | 0.00%0.012 | 0 | 0.00%0.012 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.